These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 33586025

  • 21. Hexane insoluble fraction from purple rice extract improves steatohepatitis and fibrosis via inhibition of NF-κB and JNK signaling.
    Naiki-Ito A, Yeewa R, Xiaochen K, Taychaworaditsakul W, Naiki T, Kato H, Nagayasu Y, Chewonarin T, Takahashi S.
    Food Funct; 2024 Aug 12; 15(16):8562-8571. PubMed ID: 39072556
    [Abstract] [Full Text] [Related]

  • 22. Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice.
    Susutlertpanya W, Wakuda H, Otani N, Kuramoto T, Li L, Kuranari M, Sekiguchi A, Kudo H, Uchida T, Imai H, Uemura N.
    Life Sci; 2019 Jul 01; 228():251-257. PubMed ID: 31078545
    [Abstract] [Full Text] [Related]

  • 23. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J, Vijayakumar A, Ghoshal S, Marchand B, Yi S, Kornyeyev D, Zagorska A, Hollenback D, Walker K, Liu K, Pendem S, Newstrom D, Brockett R, Mikaelian I, Kusam S, Ramirez R, Lopez D, Li L, Fuchs BC, Breckenridge DG.
    J Hepatol; 2020 Oct 01; 73(4):896-905. PubMed ID: 32376414
    [Abstract] [Full Text] [Related]

  • 24. Comprehensive characterization of metabolic, inflammatory and fibrotic changes in a mouse model of diet-derived nonalcoholic steatohepatitis.
    Kim MB, Lee Y, Bae M, Kang H, Pham TX, Hu S, Lee JY, Park YK.
    J Nutr Biochem; 2020 Nov 01; 85():108463. PubMed ID: 32891893
    [Abstract] [Full Text] [Related]

  • 25. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G, Jackson CV, Zimmerman K, Zhang LK, Finnearty CM, Sandusky GE, Zhang G, Peterson RG, Wang YJ.
    BMC Gastroenterol; 2019 Mar 18; 19(1):41. PubMed ID: 30885145
    [Abstract] [Full Text] [Related]

  • 26. Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH).
    Han L, Bittner S, Dong D, Cortez Y, Dulay H, Arshad S, Shen WJ, Kraemer FB, Azhar S.
    Mol Cell Endocrinol; 2019 Dec 01; 498():110538. PubMed ID: 31415794
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein.
    Yimin, Furumaki H, Matsuoka S, Sakurai T, Kohanawa M, Zhao S, Kuge Y, Tamaki N, Chiba H.
    Lab Invest; 2012 Feb 01; 92(2):265-81. PubMed ID: 22064320
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Oleuropein prevents the progression of steatohepatitis to hepatic fibrosis induced by a high-fat diet in mice.
    Kim SW, Hur W, Li TZ, Lee YK, Choi JE, Hong SW, Lyoo KS, You CR, Jung ES, Jung CK, Park T, Um SJ, Yoon SK.
    Exp Mol Med; 2014 Apr 25; 46(4):e92. PubMed ID: 24763197
    [Abstract] [Full Text] [Related]

  • 31. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
    Kubota N, Kado S, Kano M, Masuoka N, Nagata Y, Kobayashi T, Miyazaki K, Ishikawa F.
    Clin Exp Pharmacol Physiol; 2013 Jul 25; 40(7):422-30. PubMed ID: 23611112
    [Abstract] [Full Text] [Related]

  • 32. Withaferin A Improves Nonalcoholic Steatohepatitis in Mice.
    Patel DP, Yan T, Kim D, Dias HB, Krausz KW, Kimura S, Gonzalez FJ.
    J Pharmacol Exp Ther; 2019 Nov 25; 371(2):360-374. PubMed ID: 31420528
    [Abstract] [Full Text] [Related]

  • 33. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Chai C, Cox B, Yaish D, Gross D, Rosenberg N, Amblard F, Shemuelian Z, Gefen M, Korach A, Tirosh O, Lanton T, Link H, Tam J, Permyakova A, Ozhan G, Citrin J, Liao H, Tannous M, Hahn M, Axelrod J, Arretxe E, Alonso C, Martinez-Arranz I, Betés PO, Safadi R, Salhab A, Amer J, Tber Z, Mengshetti S, Giladi H, Schinazi RF, Galun E.
    Gastroenterology; 2020 Sep 25; 159(3):999-1014.e9. PubMed ID: 32450149
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats.
    Sánchez-Quevedo J, Ocampo-Rodríguez E, Alvarez-Ayala E, Rodríguez-López A, Duarte-Vázquez MA, Rosado JL, Rodríguez-Fragoso L.
    BMC Pharmacol Toxicol; 2022 Sep 29; 23(1):75. PubMed ID: 36175992
    [Abstract] [Full Text] [Related]

  • 36. Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: Insight on hedgehog/Gli and Wnt/β-catenin signaling crosstalk.
    El-Derany MO, El-Demerdash E.
    Biochem Pharmacol; 2020 Jul 29; 177():113942. PubMed ID: 32240652
    [Abstract] [Full Text] [Related]

  • 37. The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    Bae CR, Zhang H, Kwon YG.
    PLoS One; 2020 Jul 29; 15(12):e0243497. PubMed ID: 33275637
    [Abstract] [Full Text] [Related]

  • 38. CD47 Deficiency in Mice Exacerbates Chronic Fatty Diet-Induced Steatohepatitis Through Its Role in Regulating Hepatic Inflammation and Lipid Metabolism.
    Tao HC, Chen KX, Wang X, Chen B, Zhao WO, Zheng Y, Yang YG.
    Front Immunol; 2020 Jul 29; 11():148. PubMed ID: 32158445
    [Abstract] [Full Text] [Related]

  • 39. Moringa oleifera Improves MAFLD by Inducing Epigenetic Modifications.
    Monraz-Méndez CA, Escutia-Gutiérrez R, Rodriguez-Sanabria JS, Galicia-Moreno M, Monroy-Ramírez HC, Sánchez-Orozco L, García-Bañuelos J, De la Rosa-Bibiano R, Santos A, Armendáriz-Borunda J, Sandoval-Rodríguez A.
    Nutrients; 2022 Oct 11; 14(20):. PubMed ID: 36296907
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis.
    Yamada T, Kashiwagi Y, Rokugawa T, Kato H, Konishi H, Hamada T, Nagai R, Masago Y, Itoh M, Suganami T, Ogawa Y, Abe K.
    Magn Reson Imaging; 2019 Apr 11; 57():210-217. PubMed ID: 30465867
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.